Plasma insulin profiles after subcutaneous injection: how close can we get to physiology in people with diabetes?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Plasma insulin profiles after subcutaneous injection: how close can we get to physiology in people with diabetes?

Published:2015-09-23 Issue:11 Volume:17 Page:1011-1020
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Home P. D.¹

Affiliation:

1. Institute for Cellular Medicine—Diabetes Newcastle University Newcastle upon Tyne UK

Funder

Eli Lilly and Company

Merck

Novo Nordisk

Sanofi

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12501

Reference93 articles.

1. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

3. Comparison of insulins detemir and glargine: effects on glucose disposal, hepatic glucose release and the central nervous system

4. Comparison of Insulin Aspart and Lispro

5. Insulin therapy for type 2 diabetes

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin enhances acid-sensing ion channel currents in rat primary sensory neurons;Scientific Reports;2024-08-05

2. Postprandial Glucose Excursions with Ultra-Rapid Insulin Analogs in Hybrid Closed-Loop Therapy for Adults with Type 1 Diabetes;Diabetes Technology & Therapeutics;2024-07-01

3. Ultra rapid lispro improves postprandial glucose control versus lispro in combination with basal insulin: a study based on CGM in type 2 diabetes in China;Frontiers in Endocrinology;2024-05-07

4. Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label study;Diabetes, Obesity and Metabolism;2024-04

5. Recent advances in oral insulin delivery technologies;Journal of Controlled Release;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3